4 research outputs found

    Synthesis of chiral saturated heterocycles from diazo compounds for pharmaceutical screening collections

    Get PDF
    New synthetic methods that enable rapid access to new heterocyclic structures in biologically relevant chemical space provide important opportunities in drug discovery. In this thesis, novel saturated heterocycles were targeted as C(sp3)-rich motifs to enrich existing pharmaceutical compound libraries. Initially, the synthesis of 2,2-disubstituted saturated nitrogen heterocycles, as 2-aryl proline analogues, is described. These products are synthesised through an N–H insertion of diazo compounds followed by one-pot cyclisation using mild base. The use of the same method to access 4- to 7-membered scaffolds is shown. The flexibility of the methodology is demonstrated by application to drug and natural product functionalisation. The utility of the products is shown by various important derivatisation reactions. Subsequently, the 4-membered azetidine products, synthesised by N–H insertion and cyclisation, are ring expanded to 6-membered 1,3-oxazinan-2-one products. Through exploration of the scope and mechanism of this 4- to 6-membered ring expansion a new methodology is developed for generating new leads for drug discovery. Finally, the N–H insertion of diazo compounds is coupled with a new enantioselective cyclisation reaction to synthesise enantioenriched spiroazetidines. This cyclisation step makes use of a new asymmetric phase transfer catalyst to achieve high er. A range of spiroazetidines are synthesised and the mechanism of the asymmetric phase transfer catalysis is discussed. A summary of specific conclusions and future work can be found at the end of each chapter. The final section provides experimental details.Open Acces

    Investigation of Carbocationic Rearrangements by the ICAR Program

    No full text

    Isolation of small molecular weight bioactive compounds and polysaccharides from seaweeds (Phaeophyceae and Rhodophyceae)

    Get PDF
    Seaweeds were consumed as staple food items of the cuisines in many Asian countries, and are considered as essential components of a healthy diet. The pharmacological potential of ethyl acetate-methanol (EtOAc-MeOH) extract of ten species of seaweeds belonging to the subclasses Dictyotophycidae, Rhodymeniophycidae, and Corallinophycidae against progressive lifestyle diseases was determined by various in vitro models. Among the studied species, the organic extracts of Gracilaria salicornia and Padina tetrastromatica exhibited potential dipeptidyl�peptidase-4 inhibiting activity (IC50 ~ 0.03 mg mL-1 ) and angiotensin converting enzyme-I inhibitory property (ACE-I) (IC50 0.12 mg mL-1 ) compared to those displayed by other studied species. The organic extracts of G. salicornia and P. tetrastromatica also displayed significantly greater attenuation properties against pro-inflammatory cyclooxygenase-2 and 5-lipoxygenase (IC50 0.98-1.34 mg mL-1 , P < 0.05) compared to those derived from other species (IC50 1.99- 5.02 mg mL-1 ). The nuclear magnetic resonance-guided dereplication of organic extracts of the studied seaweed species recognized the co-linearity between the bioactive potential and downfield electronegative functionalities. These results recognized the significance of the organic extracts of G. salicornia and P. tetrastromatica to isolate compounds for functional food applications against oxidative stress and induced diseases, such as diabetes, hypertension, and inflammatio
    corecore